BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scaife JE, Barnett GC, Noble DJ, Jena R, Thomas SJ, West CM, Burnet NG. Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment. Br J Radiol. 2015;88:20150172. [PMID: 26084351 DOI: 10.1259/bjr.20150172] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Andreassen C, Eriksen J, Jensen K, Hansen C, Sørensen B, Lassen P, Alsner J, Schack L, Overgaard J, Grau C. IMRT – Biomarkers for dose escalation, dose de-escalation and personalized medicine in radiotherapy for head and neck cancer. Oral Oncology 2018;86:91-9. [DOI: 10.1016/j.oraloncology.2018.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
2 Xu L, Osei B, Osei E. A review of radiation genomics: integrating patient radiation response with genomics for personalised and targeted radiation therapy. J Radiother Pract 2019;18:198-209. [DOI: 10.1017/s1460396918000547] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Benitez CM, Knox SJ. Harnessing genome-wide association studies to minimize adverse radiation-induced side effects. Radiat Oncol J 2020;38:226-35. [PMID: 33233031 DOI: 10.3857/roj.2020.00556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Berger T, Noble DJ, Shelley LE, Hopkins KI, Mclaren DB, Burnet NG, Nailon WH. Response to letter to the editor of radiotherapy and oncology regarding the paper entitled “50 years of radiotherapy research: Evolution, trends and lessons for the future“ by Berger et al. (December 2021, Volume 165). Radiotherapy and Oncology 2022. [DOI: 10.1016/j.radonc.2022.04.001] [Reference Citation Analysis]
5 Mathew ST, Johansson P, Gao Y, Fasth A, Ek T, Hammarsten O. A flow cytometry assay that measures cellular sensitivity to DNA-damaging agents, customized for clinical routine laboratories. Clin Biochem 2016;49:566-72. [PMID: 26779995 DOI: 10.1016/j.clinbiochem.2016.01.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
6 Pavlopoulou A, Bagos PG, Koutsandrea V, Georgakilas AG. Molecular determinants of radiosensitivity in normal and tumor tissue: A bioinformatic approach. Cancer Letters 2017;403:37-47. [DOI: 10.1016/j.canlet.2017.05.023] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
7 Zhao WB, Qiu MM, Wen BX. Clinical application of precise radiotherapy in rectal cancer. Shijie Huaren Xiaohua Zazhi 2016; 24(5): 714-721 [DOI: 10.11569/wcjd.v24.i5.714] [Reference Citation Analysis]
8 Andreassen CN, Schack LMH, Laursen LV, Alsner J. Radiogenomics – current status, challenges and future directions. Cancer Letters 2016;382:127-36. [DOI: 10.1016/j.canlet.2016.01.035] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 8.3] [Reference Citation Analysis]
9 Liu J, Han M, Yue Z, Dong C, Wen P, Zhao G, Wu L, Xia J, Bin Y. Prediction of Radiosensitivity in Head and Neck Squamous Cell Carcinoma Based on Multiple Omics Data. Front Genet 2020;11:960. [PMID: 33014019 DOI: 10.3389/fgene.2020.00960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Vivarelli S, Salemi R, Candido S, Falzone L, Santagati M, Stefani S, Torino F, Banna GL, Tonini G, Libra M. Gut Microbiota and Cancer: From Pathogenesis to Therapy. Cancers (Basel) 2019;11:E38. [PMID: 30609850 DOI: 10.3390/cancers11010038] [Cited by in Crossref: 143] [Cited by in F6Publishing: 129] [Article Influence: 47.7] [Reference Citation Analysis]
11 Vinnikov V, Hande MP, Wilkins R, Wojcik A, Zubizarreta E, Belyakov O. Prediction of the Acute or Late Radiation Toxicity Effects in Radiotherapy Patients Using Ex Vivo Induced Biodosimetric Markers: A Review. J Pers Med 2020;10:E285. [PMID: 33339312 DOI: 10.3390/jpm10040285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Burnet NG, Scaife JE, Romanchikova M, Thomas SJ, Bates AM, Wong E, Noble DJ, Shelley LE, Bond SJ, Forman JR, Hoole AC, Barnett GC, Brochu FM, Simmons MP, Jena R, Harrison K, Yeap PL, Drew A, Silvester E, Elwood P, Pullen H, Sultana A, Seah SY, Wilson MZ, Russell SG, Benson RJ, Rimmer YL, Jefferies SJ, Taku N, Gurnell M, Powlson AS, Schönlieb CB, Cai X, Sutcliffe MP, Parker MA. Applying physical science techniques and CERN technology to an unsolved problem in radiation treatment for cancer: the multidisciplinary 'VoxTox' research programme. CERN Ideasq J Exp Innov 2017;1:3-12. [PMID: 29177202 DOI: 10.23726/cij.2017.457] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
13 Lotte VDW, Barrera E. Miguel A, David A, Patrick B, Pierre B, Erik B, Renée B, Patricia C, Jenny C, Ananya C, Gilles D, Sylvian D, Dunning Alison M, Elliott Rebecca M, Dawn E, Corinne F, Marzia F, Sara G, Carsten H, Higginson Daniel S, Kerns Sarah L, Kerstie J, Meritxell M, Maarten L, Mónica R, Tiziana R, Andreas R, Rosenstein Barry S, Ruysscher Dirk D, Ahmed S, Claudia S, Petra S, Paloma S, Elena S, Hilary S, Holly S, Veerle S, Paul S, Begoña T, Talbot Christopher J, Riccardo V, Ana V, Liv V, Veldwijk Marlon R, Tim W, Adam W, West Catharine M, Yolande L. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study). Lung Cancer 2022. [DOI: 10.1016/j.lungcan.2022.03.010] [Reference Citation Analysis]
14 Moulton CR, House MJ, Lye V, Tang CI, Krawiec M, Joseph DJ, Denham JW, Ebert MA. Spatial features of dose-surface maps from deformably-registered plans correlate with late gastrointestinal complications. Phys Med Biol 2017;62:4118-39. [PMID: 28445167 DOI: 10.1088/1361-6560/aa663d] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
15 Volpe S, Pepa M, Zaffaroni M, Bellerba F, Santamaria R, Marvaso G, Isaksson LJ, Gandini S, Starzyńska A, Leonardi MC, Orecchia R, Alterio D, Jereczek-Fossa BA. Machine Learning for Head and Neck Cancer: A Safe Bet?-A Clinically Oriented Systematic Review for the Radiation Oncologist. Front Oncol 2021;11:772663. [PMID: 34869010 DOI: 10.3389/fonc.2021.772663] [Reference Citation Analysis]
16 Niebuhr NI, Splinter M, Bostel T, Seco J, Hentschke CM, Floca RO, Hörner-Rieber J, Alber M, Huber P, Nicolay NH, Pfaffenberger A. Biologically consistent dose accumulation using daily patient imaging. Radiat Oncol 2021;16:65. [PMID: 33823885 DOI: 10.1186/s13014-021-01789-3] [Reference Citation Analysis]
17 Johansson P, Fasth A, Ek T, Hammarsten O. Validation of a flow cytometry-based detection of γ-H2AX, to measure DNA damage for clinical applications. Cytometry B Clin Cytom 2017;92:534-40. [PMID: 27060560 DOI: 10.1002/cyto.b.21374] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
18 Kang J, Rancati T, Lee S, Oh JH, Kerns SL, Scott JG, Schwartz R, Kim S, Rosenstein BS. Machine Learning and Radiogenomics: Lessons Learned and Future Directions. Front Oncol 2018;8:228. [PMID: 29977864 DOI: 10.3389/fonc.2018.00228] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
19 Alsbeih G, Al-Meer RS, Al-Harbi N, Bin Judia S, Al-Buhairi M, Venturina NQ, Moftah B. Gender bias in individual radiosensitivity and the association with genetic polymorphic variations. Radiother Oncol 2016;119:236-43. [PMID: 26987471 DOI: 10.1016/j.radonc.2016.02.034] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
20 Rosenstein BS. Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity. Semin Radiat Oncol 2017;27:300-9. [PMID: 28865512 DOI: 10.1016/j.semradonc.2017.04.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
21 de Araujo Farias V, O'Valle F, Serrano-Saenz S, Anderson P, Andrés E, López-Peñalver J, Tovar I, Nieto A, Santos A, Martín F, Expósito J, Oliver FJ, de Almodóvar JMR. Exosomes derived from mesenchymal stem cells enhance radiotherapy-induced cell death in tumor and metastatic tumor foci. Mol Cancer 2018;17:122. [PMID: 30111323 DOI: 10.1186/s12943-018-0867-0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 12.0] [Reference Citation Analysis]
22 Morton LM, Ricks-Santi L, West CML, Rosenstein BS. Radiogenomic Predictors of Adverse Effects following Charged Particle Therapy. Int J Part Ther 2018;5:103-13. [PMID: 30505881 DOI: 10.14338/IJPT-18-00009.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Cullen D, Bryant J, Maguire A, Medipally D, Mcclean B, Shields L, Noone E, Bradshaw S, Finn M, Dunne M, Shannon AM, Armstrong J, Howe O, Meade AD, Lyng FM. Raman spectroscopy of lymphocytes for the identification of prostate cancer patients with late radiation toxicity following radiotherapy. Translational Biophotonics 2020;2. [DOI: 10.1002/tbio.201900035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Hamstra DA, Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, Zimberg S, Forsythe K, Zhang H, Soffen E, Francke P, Mantz C, Rossi P, DeWeese T, Daignault-Newton S, Fischer-Valuck BW, Chundury A, Gay H, Bosch W, Michalski J. Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial. Int J Radiat Oncol Biol Phys 2017;97:976-85. [PMID: 28209443 DOI: 10.1016/j.ijrobp.2016.12.024] [Cited by in Crossref: 158] [Cited by in F6Publishing: 140] [Article Influence: 26.3] [Reference Citation Analysis]
25 Tomasik B, Chałubińska-Fendler J, Chowdhury D, Fendler W. Potential of serum microRNAs as biomarkers of radiation injury and tools for individualization of radiotherapy. Transl Res 2018;201:71-83. [PMID: 30021695 DOI: 10.1016/j.trsl.2018.06.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]